Evidence map›Paper›PMID 42574703›Full record

ArticleAIDS education and prevention : official publication of the International Society for AIDS Education2026

Development of a Layperson Injector Training for the Home-Based Administration of Long-Acting Injectable Antiretroviral Therapies for Persons With HIV.

Beth Bourdeau, Alicia T Bolton, Jonathan Van Nuys, Michelle Palomares, Erin Moore, Greg M Rebchook, Starley B Shade, Orlando O Harris, Kate Buchacz, Jesse O'Shea and 1 more

Abstract read
In one paragraph

Article in AIDS education and prevention : official publication of the International Society for AIDS Education, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Beth BourdeauDepartment of Medicine, University of California, San Francisco, San Francisco, California.
Alicia T BoltonDepartment of Medicine, University of California, San Francisco, San Francisco, California.
Jonathan Van NuysDepartment of Medicine, University of California, San Francisco, San Francisco, California.
Michelle PalomaresDepartment of Medicine, University of California, San Francisco, San Francisco, California.
Erin MooreDepartment of Medicine, University of California, San Francisco, San Francisco, California.
Greg M RebchookDepartment of Medicine, University of California, San Francisco, San Francisco, California.
Starley B ShadeDepartment of Medicine, University of California, San Francisco, San Francisco, California.
Orlando O HarrisDepartment of Medicine, University of California, San Francisco, San Francisco, California.
Kate BuchaczDivision of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Jesse O'SheaDivision of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Parya SaberiDepartment of Medicine, University of California, San Francisco, San Francisco, California.

Funding

ACL HHS U01PS005259Intramural CDC HHS CC999999NCHHSTP CDC HHS U01 PS005259
6 · The paper itself

Abstract

Long-acting injectable antiretroviral therapy (LAI-ART) has the potential to transform HIV treatment by improving adherence, reducing stigma, and expanding access through decentralized care. The INVITE-Home study evaluates home-based LAI-ART administration by trained nonmedical treatment buddies (TBYs) selected by people with HIV (PWH). This article describes the development of a TBY training curriculum guided by Adult Learning Theory and refined through iterative stakeholder input. The five-phase process included review of existing materials, qualitative interviews with clinicians, PWH, and TBYs

Indexed as

Anti-HIV AgentsAnti-Retroviral AgentsHIV InfectionsAdherence InterventionsAdultCurriculumDelayed-Action PreparationsFemaleHome Care ServicesHumansMaleMedication AdherenceAnti-HIV AgentsAnti-Retroviral AgentsDelayed-Action Preparationsalternative care delivery modelantiretroviral therapyhome-based administrationlayperson injectorlong-acting injectablesnon-clinic setting

Identifiers

PMID42574703
PMCPMC13521325

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.